Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines. (Q40192191)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180681%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

title

Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180681%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180681%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Gisela Orozco

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180681%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

T Rodríguez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180681%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

R Méndez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180681%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

A Del Campo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180681%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

N Aptsiauri

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180681%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

G Pawelec

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180681%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

D Schadendorf

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180681%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

F Ruiz-Cabello

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180681%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

F Garrido

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180681%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

language of work or name

English

0 references

publication date

20 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180681%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180681%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180681%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180681%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

123-133

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180681%20AND%20SRC:MED&resulttype=core&format=json

Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis

23 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00251-006-0171-9

Modulation of gene expression by the MHC class II transactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00251-006-0171-9

Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00251-006-0171-9

CD4+ Th2 cell recognition of HLA-DR-restricted epitopes derived from CAMEL: a tumor antigen translated in an alternative open reading frame

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00251-006-0171-9

Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00251-006-0171-9

Lack of IFN-gamma-mediated induction of the class II transactivator (CIITA) through promoter methylation is predominantly found in developmental tumor cell lines

21 January 2018

1 reference

12 December 2020

Phenotypic dynamics of tumor progression in human malignant melanoma

1 reference

12 December 2020

Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1

1 reference

12 December 2020

DR (Ia-like) antigens on human melanoma cells. Serological detection and immunochemical characterization

1 reference

12 December 2020

Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma

1 reference

12 December 2020

Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas

1 reference

12 December 2020

Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.

1 reference

12 December 2020

Immunoselection by T lymphocytes generates repeated MHC class I-deficient metastatic tumor variants

1 reference

12 December 2020

Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines

1 reference

12 December 2020

Class II transactivator regulates the expression of multiple genes involved in antigen presentation

1 reference

12 December 2020

The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes

1 reference

12 December 2020

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

1 reference

12 December 2020

Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma

1 reference

12 December 2020

An isotype-specific trans-acting factor is defective in a mutant B cell line that expresses HLA-DQ, but not -DR or -DP

1 reference

12 December 2020

Help for cytotoxic-T-cell responses is mediated by CD40 signalling

1 reference

12 December 2020

Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA.

1 reference

12 December 2020

DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas

1 reference

12 December 2020

Regulation of MHC class II gene expression by the class II transactivator

1 reference

12 December 2020

ESTDAB: a collection of immunologically characterised melanoma cell lines and searchable databank

1 reference

12 December 2020

Biological implications of HLA-DR expression in tumours

1 reference

12 December 2020

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

1 reference

12 December 2020

Use of monoclonal antibodies in detection of melanoma-associated antigens in intact human tumors

1 reference

12 December 2020

HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx

1 reference

12 December 2020

An isotype-specific activator of major histocompatibility complex (MHC) class II genes that is independent of class II transactivator

1 reference

12 December 2020

Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens

1 reference

12 December 2020

Immunohistological evaluation of MHC class I and II antigen expression on nevi and melanoma: relation to biology of melanoma

1 reference

12 December 2020

Natural history of HLA expression during tumour development.

1 reference

12 December 2020

Detection of spontaneous CD4+ T-cell responses in melanoma patients against a tyrosinase-related protein-2-derived epitope identified in HLA-DRB1*0301 transgenic mice

1 reference

12 December 2020

Melanocytic atypia in dysplastic nevi. Immunohistochemical and cytophotometrical analysis

1 reference

12 December 2020

Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-gamma in haematopoietic tumour cells

1 reference

12 December 2020

Class II transactivator: mastering the art of major histocompatibility complex expression

1 reference

12 December 2020

An evaluation of the prognostic significance of HLA-DR expression in gastric carcinoma

1 reference

12 December 2020

CD4(+) T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: association with NY-ESO-1 antibody production

1 reference

12 December 2020

Lack of CIITA expression is central to the absence of antigen presentation functions of trophoblast cells and is caused by methylation of the IFN-gamma inducible promoter (PIV) of CIITA.

1 reference

12 December 2020

Regulation of MHC class II expression in human T-cell malignancies

1 reference

12 December 2020

DNA content and MHC class II antigen expression in malignant melanoma: clinical course

1 reference

12 December 2020

Regulation of MHC class II expression, a unique regulatory system identified by the study of a primary immunodeficiency disease.

1 reference

12 December 2020

Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter

1 reference

12 December 2020

Phenotypic and genetic analysis of HLA class I and HLA-DR antigen expression on human melanomas

1 reference

12 December 2020

Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression

1 reference

12 December 2020

Differential expression of HLA-DR, DQ, and DP antigens in primary and metastatic melanoma

1 reference

12 December 2020

Expression of HLA-D subloci DR and DQ by breast carcinomas is correlated with distinct parameters of favourable prognosis

1 reference

12 December 2020

Methods in laboratory investigation. Immunoelectron microscopic methods for demonstration of antigens on normal human melanocytes and other epidermal cells

1 reference

12 December 2020

MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction

1 reference

12 December 2020

Tumor progression in human malignant melanoma: five stages defined by their antigenic phenotypes

1 reference

12 December 2020

Unresponsiveness to interferon associated with STAT1 protein deficiency in a gastric adenocarcinoma cell line.

1 reference

12 December 2020

Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.

1 reference

12 December 2020

10.1007/S00251-006-0171-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180681%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference